Today is the last day of trading for Starpharma until a new CEO takes the reins. Keep an eye on Clarity Pharmaceuticals (CU6) today and Monday for an announcement of a director resignation.
Hopefully, praying actually that Cheryl Mayley resigns as a Clarity director to focus fully on Starpharma as our new CEO.
Has the worm turned for Starpharma? Have they learned the lessons of the past? There is so much work ahead of her that surely she needs to be laser focused on the success of Starpharma and value creation for it’s shareholders.
Perhaps though the SPL Chairman will allow Cheryl to remain as a director (with him) at CU6. If this comes to pass it would be another red flag for the prospects of Starpharma IMO.
C’mon Cheryl, do the right thing.
DYOR
New CEO’s focus
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $49.44M | |||
| Open | High | Low | Value | Volume |
| 11.5¢ | 12.5¢ | 10.5¢ | $132.0K | 1.162M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 535926 | 11.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.5¢ | 100000 | 1 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
12.0¢ |
Change
0.000 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 11.0¢ | 12.5¢ | 10.5¢ | 991112 | ||
| Last updated 15.53pm 03/05/2024 ? | |||||
| SPL (ASX) Chart |